Approval · Notice of Compliance 1203 · 2000
TUSSIONEX: Notice of Compliance 1203
Issued November 10, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1203
- Date
- November 10, 2000
- Company
- Aventis Pharma Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antitussive, antihistamine
Products in this notice
Medicinal ingredients
- PHENYLTOLOXAMINE CITRATE 10 MG per TAB
- HYDROCODONE BITARTRATE 5 MG per TAB
- PHENYLTOLOXAMINE CITRATE 10 MG per 5ML
- HYDROCODONE BITARTRATE 5 MG per 5ML